While the aforementioned evidence illustrated that MAGE-A11 may potentiate cancer development at least in part through the functional collaboration with MAGE-A6, the clinical value of the MAGE-A11 expression in association with MAGE-A6 expression has not been fully elucidated. Here, MAGEA6 is linked to cancer.